Gliclazide tablets containing 80mg Gliclazide, an oral sulfonylurea anti-diabetic agent used to lower blood glucose levels in patients with type 2 diabetes mellitus.

Composition:
Each tablet contains 80mg Gliclazide as active ingredient plus excipients like lactose, magnesium stearate and methyl hydroxybenzoate.

Medication:
Gliclazide stimulates insulin secretion from pancreatic beta cells, thereby lowering blood glucose.

Therapeutic Category:
Anti-diabetic

Prescription/OTC:
Gliclazide tablets are available by prescription only.

Variant/Dosage:
Pack of 10 tablets. Recommended dose is 80-320mg daily.

Product Substitutes:
Glyciphage by Franco-Indian, Diamicron by Servier.

Manufacturer/Marketer:
Manufactured and marketed by Emcure Pharmaceuticals Limited.

Country of Origin:
India